TLR initiate a cascade that begins with activation of canonical (classical) NF-kB and ERK MAPK pathways, amplified by induced host mediators, with subsequent enrollment of STAT3 activities, which affects essentially all cell types present in the tumor. The gene discussed is NFKB1; the disease is neoplasm.